Literature DB >> 28587770

Functional communication between PKC-targeted cardiac troponin I phosphorylation sites.

Sarah E Lang1, Tamara K Stevenson2, Tabea M Schatz2, Brandon J Biesiadecki3, Margaret V Westfall4.   

Abstract

Increased protein kinase C (PKC) activity is associated with heart failure, and can target multiple cardiac troponin I (cTnI) residues in myocytes, including S23/24, S43/45 and T144. In earlier studies, cTnI-S43D and/or -S45D augmented S23/24 and T144 phosphorylation, which suggested there is communication between clusters. This communication is now explored by evaluating the impact of phospho-mimetic cTnI S43/45D combined with S23/24D (cTnIS4D) or T144D (cTnISDTD). Gene transfer of epitope-tagged cTnIS4D and cTnISDTD into adult cardiac myocytes progressively replaced endogenous cTnI. Partial replacement with cTnISDTD or cTnIS4D accelerated the time to peak (TTP) shortening and time to 50% re-lengthening (TTR50%) on day 2, but peak shortening was only diminished by cTnIS4D. Extensive cTnIS4D replacement continued to accelerate TTP, and decrease shortening amplitude, while TTR50% returned to baseline levels on day 4. In contrast, cTnISDTD modestly reduced shortening amplitude and continued to accelerate myocyte TTP and TTR50%. These results indicate cTnIS43/45 communicates with S23/24 and T144, with S23/24 exacerbating and T144 attenuating the S43/45D-dependent functional deficit. In addition, more severe functional alterations in cTnIS4D myocytes were accompanied by higher levels of secondary phosphorylation compared to cTnISDTD. These results suggest that secondary phosphorylation helps to maintain steady-state contractile function during chronic cTnI phosphorylation at PKC sites.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac myocyte; Contractile function; Myofilament; Phosphorylation; Troponin I

Mesh:

Substances:

Year:  2017        PMID: 28587770      PMCID: PMC5555030          DOI: 10.1016/j.abb.2017.05.019

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  49 in total

1.  Combined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment.

Authors:  Benjamin R Nixon; Shane D Walton; Bo Zhang; Elizabeth A Brundage; Sean C Little; Mark T Ziolo; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-03-19       Impact factor: 5.000

2.  Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.

Authors:  Sean T DeGrande; Sean C Little; Derek J Nixon; Patrick Wright; Jedidiah Snyder; Wen Dun; Nathaniel Murphy; Ahmet Kilic; Robert Higgins; Philip F Binkley; Penelope A Boyden; Cynthia A Carnes; Mark E Anderson; Thomas J Hund; Peter J Mohler
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

3.  Differential protein expression and basal lamina remodeling in human heart failure.

Authors:  Evelyn H Kim; Vladimir I Galchev; Jin Young Kim; Sean A Misek; Tamara K Stevenson; Matthew D Campbell; Francis D Pagani; Sharlene M Day; T Craig Johnson; Joseph G Washburn; Karen L Vikstrom; Daniel E Michele; David E Misek; Margaret V Westfall
Journal:  Proteomics Clin Appl       Date:  2016-01-25       Impact factor: 3.494

4.  Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart.

Authors:  Pingbo Zhang; Jonathan A Kirk; Weihua Ji; Cristobal G dos Remedios; David A Kass; Jennifer E Van Eyk; Anne M Murphy
Journal:  Circulation       Date:  2012-09-12       Impact factor: 29.690

Review 5.  Tuning the molecular giant titin through phosphorylation: role in health and disease.

Authors:  Carlos Hidalgo; Henk Granzier
Journal:  Trends Cardiovasc Med       Date:  2013-01-05       Impact factor: 6.677

6.  Differential contribution of troponin I phosphorylation sites to the endothelin-modulated contractile response.

Authors:  Margaret V Westfall; Adonia M Lee; Dustin A Robinson
Journal:  J Biol Chem       Date:  2005-10-18       Impact factor: 5.157

7.  Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts.

Authors:  Viola Kooij; Ronald J Holewinski; Anne M Murphy; Jennifer E Van Eyk
Journal:  J Mol Cell Cardiol       Date:  2013-04-22       Impact factor: 5.000

8.  Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites.

Authors:  Eiki Takimoto; David G Soergel; Paul M L Janssen; Linda B Stull; David A Kass; Anne M Murphy
Journal:  Circ Res       Date:  2004-01-15       Impact factor: 17.367

9.  Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity.

Authors:  Eileen M Burkart; Marius P Sumandea; Tomoyoshi Kobayashi; Mahta Nili; Anne F Martin; Earl Homsher; R John Solaro
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

10.  Protein kinase C phosphomimetics alter thin filament Ca2+ binding properties.

Authors:  Bin Liu; Joseph J Lopez; Brandon J Biesiadecki; Jonathan P Davis
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more
  3 in total

Review 1.  Troponin I modulation of cardiac performance: Plasticity in the survival switch.

Authors:  Brandon J Biesiadecki; Margaret V Westfall
Journal:  Arch Biochem Biophys       Date:  2019-01-23       Impact factor: 4.013

2.  Cardiac contractile dysfunction and protein kinase C-mediated myofilament phosphorylation in disease and aging.

Authors:  Vani S Ravichandran; Himanshu J Patel; Francis D Pagani; Margaret V Westfall
Journal:  J Gen Physiol       Date:  2019-07-31       Impact factor: 4.086

3.  Secondary phosphorylation in myocytes expressing FLAG-tagged and non-tagged phospho-mimetic cardiac troponin I.

Authors:  Sarah E Lang; Tamara K Stevenson; Tabea M Schatz; Brandon J Biesiadecki; Margaret V Westfall
Journal:  Data Brief       Date:  2017-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.